Connect with us
MARE BALTICUM Gaming & TECH Summit 2024

Artificial Intelligence

The market is expected to grow at a CAGR of 9.04% during the forecast period from 2021 to 2030

Published

on

New York, July 29, 2021 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Global Urology Care Devices and Platforms Market: Focus on Product Type, Application, Indication, End User, and Regional Analysis” – https://www.reportlinker.com/p06124032/?utm_source=GNW

• Product- Devices (Conventional Devices and Advanced Devices) and Platforms
• Application- Treatment and Diagnosis and Monitoring
• Indication- Kidney Diseases, Urological Cancer and Benign Prostatic Hyperlapsia, Pelvic Organ Prolapse, and Other Diseases
• End User- Hospitals, Ambulatory Surgery Centers, and Clinics, Dialysis Centers, and Home Care Settings

Regional Segmentation

• North America – U.S., Canada
• Europe – Germany, U.K, France, Italy, Spain, and Rest-of-Europe
• Asia-Pacific – Japan, China, India, South Korea, Australia and New Zealand, and Rest-of-Asia-Pacific
• Latin America – Brazil, Mexico, Argentina, and Rest-of-Latin-America
• Middle East and Africa – K.S.A., Israel, South Africa, and Rest-of-Middle East and Africa

Market Growth Drivers

• Rising Prevalence of Urological Disorders
• Rising Technology Integration in Urology Care
• Product Portfolio Expansion through Mergers and Acquisitions

Market Challenges

• High Upfront Cost of Devices
• Data Privacy Concerns

Market Opportunities

• Adoption of Telesurgery in Urology Care
• Emergence of Regional Companies in Global Urology Care Devices and Platforms Market
• Development of Remote Patient Monitoring Devices

Key Companies Profiled

Avenda Health, B. Braun Melsungen AG, Becton, Dickinson and Company, Boston Scientific Corporation, Cardinal Health, Inc., Cook Group, Fresenius Medical Care AG & Co. KGaA, Intuitive Surgical, Inc., KARL STORZ SE & Co KG, Lucida Medical Ltd, Medtronic plc, Px HealthCare Ltd., Richard Wolf GmbH, Rocamed, Urologix, LLC.

How This Report Can Add Value

Who should buy this report?

• Technology/non-healthcare companies planning to enter the urology market through a platform, mobile application, or smart device
• Urological device manufacturers
• AI-enabled platform developers
• Imaging modalities companies (specifically for urology)
• Endoscope manufacturers

Key questions answered in the Global Urology Care Devices and Platforms Market Report

• How has COVID-19 impacted the adoption of urology care devices and platforms applications?
• What are the key regulations governing the urology care devices and platforms market in key regions?
• What are the technological developments projected to have the maximum influence on the global urology care devices and platforms market?
• Who are the leading players holding significant dominance in the global urology care devices and platforms market currently?
• What are the drivers and restraints for the global urology care devices and platforms market?
• Which region has the highest growth rate in the urology care devices and platform market?
• Who are the key end-users of the global urology care devices and platform market?
• Which are the emerging companies in the global urology care devices and platforms market?

Global Urology Care Devices and Platforms Market Overview

The scope of the global urology care devices and platforms market involves conventional and advanced devices as well as platforms that are used in urological disease management.The conventional devices include dialysis devices, endoscopy and urology-specific imaging devices, lasers and lithotripsy devices, endoscopy fluid management systems, insufflators, and urodynamic systems.

Furthermore, consumables such as guidewires and catheters, stents, biopsy devices, and other disposable consumables such as drainage bags, sheaths, and stone retrieval baskets are also categorized as conventional devices. The advanced devices include technology-enabled devices such as neurostimulators, robotic systems, and other emerging technology devices used for urology disorder management.

The global urology care devices and platforms market comprises of various key medical device companies and emerging companies. The major medical device companies operating in the market include Baxter International Inc., Olympus Corporation, Boston Scientific Corporation, Becton, Dickinson and Company, and Medtronic plc.

However, owing to the rising technology penetration and demand for minimally invasive procedures, various novel companies such as Axonics Modulation Technologies, Inc., Micron Medical Corporation, and robotic system companies such as Intuitive Surgical, Inc. have also entered the market and are offering advanced devices such as neurostimulators for urological treatment. Additionally, owing to the rising demand for remote patient monitoring and integration of digital solutions, emerging companies such as CareLogiQ Corp, Renalytix AI plc, and Healthy.io Ltd have entered the market and are projected to witness significant growth during the forecast period 2021-2030.

The pipeline of global urology care devices and platforms market primarily comprises advanced devices and platforms.Various companies such as Implantica AG, Micron Medical, Lucida Medical, and Neuspera Medical have products in the pipeline that are anticipated to be commercialized by the end of 2030.

The launch of these products is projected to propel technology integration in the urology care landscape.

The factors driving growth include rising prevalence of urological disorders, rising technology integration, and product portfolio expansion through mergers and acquisitions.The restraints to the global urology care devices and platforms market include high upfront cost of the devices and data privacy concerns.

The opportunities for the global urology care devices and platforms market lie in the adoption of telesurgery in urological practices, emergence of regional companies, and development of remote patient monitoring devices.

Key technology trends such as the switch from open procedures to minimally invasive procedures, inclusion of telemedicine in urology practices, remote patient monitoring devices, and integration of artificial intelligence (AI) for improved patient assessment are anticipated to influence the global urology care devices and platforms market.AI has been integrated into various healthcare applications for improved data analytics.

AI inclusion in diagnosis, medical imaging, data collection, result interpretation, and treatment planning has improved physician’s decision-making quality.

The global urology care devices and platforms market has witnessed significant technology integration in the past few years.There has been significant design- and product-level innovations in the market.

For instance, more than 5,100 patents have been filed from January 2015 -June 2021, with the highest number of filings in 2019 (1,792 patents).

During January 2018-June 2021, the global urology care devices and platforms market witnessed 50 key developments.Regulatory and legal activities were the most actively employed strategies, followed by mergers and acquisitions.

The key companies that received regulatory approvals between January 2018-June 2021 included Advanced MedTech Holdings Pte. Ltd., Baxter International Inc., Medtronic plc, Teleflex Incorporated, Axonics Modulation Technologies, Aveda Health, and Lucida Medical Ltd. Similarly, several partnerships took place between January 2018-June 2021. The aim of strategic partnerships includes new product development, strengthening of distribution network, and business expansion.

New product launches are one of the primary strategies adopted by new companies to enter in the global urology care devices and platforms market.Companies have also been working on upgrades for their existing products.

Between January 2018-June 2021, several new products were launched in the global urology care devices and platforms market.Companies such as Advanced MedTech Holdings Pte.

Ltd., B. Braun Melsungen AG, Teleflex Incorporated, and Stryker Corporation launched their products in the mentioned period. Furthermore, funding activities are critical for the entry and operation of start-ups in the global urology care devices and platforms market. Advanced MedTech Holdings is one of the prominent investors in the global urology care devices and platforms market that has regularly invested in various start-ups.

Two business models, namely, business to customer (B2C) and distributor network, are operational in the global urology care devices and platforms market.The device manufacturers often employ both the business models for ensuring a prominent local and global presence.

Furthermore, owing to the emergence of platforms companies enabling remote patient monitoring and improved imaging analytics, software-as-a-service (SaaS) is anticipated to become one of the prominent business models in the market.

The global urology care devices and platforms market report highlights that the market was valued at $13.61 billion in 2019 and is expected to reach $33.64 billion by the end of 2030. The market is expected to grow at a CAGR of 9.04% during the forecast period from 2021 to 2030.

Global Urology Care Devices and Platforms Market Drivers

The factors driving growth include rising prevalence of urological disorders, rising technology integration, and product portfolio expansion through mergers and acquisitions.The high susceptibility of diabetic patients to urinary tract infections (UTI) is a major factor for growing urological disorder cases.

Thus, with the rise in diabetic patients across the world, UTIs are becoming widespread.

There has been a shift in preference by urologists toward single use endoscopes as compared to reusables.This is due to the risk of contamination associated with reusable endoscopes.

Additionally, the usage of minimally invasive procedures as treatment for lower urinary tract symptoms (LUTS) has drastically increased since 2013.

Lastly, there have also been several key mergers and acquisitions in the field of urology that have driven the global urology care devices and platforms market. This assists the companies in gaining access to newer technologies and strengthening their product offering.

Global Urology Care Devices and Platforms Market Challenges

The restraints to the global urology care devices and platforms market include high upfront cost of the devices and data privacy concerns.

While singe use instruments such as endoscopes have benefits that outweigh those of reusable devices, a major limitation encountered with single use instruments is their high upfront cost which puts pressure on the global urology care devices and platforms market.This causes an increase in hospital expenditure which subsequently leads to higher treatment costs.

As a result, healthcare becomes both less affordable and accessible.

Data breaches are a huge source of concern for healthcare organizations as such incidents can cause legal issues and increase the risk of the practice being shut down. Such cases negatively influence the global urology care devices and platforms market and thus, pose a hindrance to the growth of the market.

Global Urology Care Devices and Platforms Market Opportunities

The opportunities for the global urology care devices and platforms market lie in the adoption of telesurgery in urological practices, emergence of regional companies, and development of remote patient monitoring devices.

Under the realm of telemedicine, telesurgery is one of the most challenging yet promising areas.Technological advancement and the development of high-speed internet with a wide bandwidth have positively influenced the field of telesurgery and telesurgical monitoring.

While telesurgery holds potential in the field of global urology care devices and platforms market, it is advancement in telecommunication technologies that will allow telesurgery’s applications in the field of education as well as assistance in urological procedures.

With more companies venturing into developing products with novel technologies, there is increased competition among the players in the global urology care devices and platforms market.While the major players in the global urology care devices and platforms market hold a larger market share, newer start-ups are focusing on entering the market by launching products that integrate concepts like artificial intelligence AI and machine learning (ML) into their devices.

This gives them an edge over the already existing products.

There are a number of remote patient monitoring devices in the global urology care devices and platforms market currently, such as CarePath by I-O Urology, CarelogiQ by CareLogiQ Corp, and KidneyIntelX by Renalytix AI plc, s. The demand for the devices is projected to grow in the future owing to the growing preference among patients and physicians, continuous patient monitoring, improvement in the decision-making process, and accelerated prognosis and treatment planning.

Impact of COVID-19 on Global Urology Care Devices and Platforms Market

In the short term, i.e., 2-4 years from 2020, COVID-19 would have a high impact on the global urology care devices and platforms market. The demand for remote patient monitoring devices is anticipated to be highest during this timeframe.

5-10 years from 2020, the resumption of elective surgeries and normalization of the supply chain would be the key factors for market recovery. Finally, in the long term, i.e., 8-12 years from 2020, the supply chain, production, and installation of conventional and advanced urology care devices are anticipated to be normalized.

Market Segmentation

Global Urology Care Devices and Platforms Market (by Product)

The global urology care devices and platforms market (by product) is segmented into conventional and advanced devices as well as platforms.The conventional devices include dialysis devices, endoscopy and urology-specific imaging devices, lasers and lithotripsy devices, endoscopy fluid management systems, insufflators, and urodynamic systems.

Furthermore, consumables such as guidewires and catheters, stents, biopsy devices, and other disposable consumables such as drainage bags, sheaths, and stone retrieval baskets are also categorized as conventional devices. The advanced devices include technology enabled devices such as neurostimulators, robotic systems, and other emerging technology devices used for urology disorder management.

Global Urology Care Devices and Platforms Market (by Application)

The global urology care devices and platforms market (by application) is segmented into treatment, and diagnostics and monitoring.In terms of opportunities, the global urology care devices and platforms market holds significant growth potential for the diagnosis and monitoring segment.

The shifting preference from at-clinic to at-home diagnostic and monitoring services presents abundant opportunities for the segment.

Global Urology Care Devices and Platforms Market (by End User)

The global urology care devices and platforms market (by end user) is segmented into hospitals, ambulatory surgery centers (ASCs), and clinics, dialysis centers, and home care settings.In terms of end user, the global urology care devices and platforms market holds significant growth opportunities in ASCs and homecare settings segment.

This is owing to the growing prevalence of urological conditions, rise in adoption of remote patient monitoring devices, and rising demand for homecare. However, the predominance of hospitals and clinics is anticipated to continue during the forecast period 2021- 2030.

Global Urology Care Devices and Platforms Market (by Indication)

The global urology care devices and platforms market (by indication) is segmented into kidney diseases, urological cancer and benign prostatic hyperplasia, pelvic organ prolapse, and other diseases.The global urology care devices and platforms market holds significant potential in urological disorders such as kidney diseases, benign prostatic hyperplasia (BPH), bladder cancer, prostate cancer, and urinary incontinence.

The rising prevalence of kidney diseases is attributed to factors such as a sedentary lifestyle, an unhealthy diet, and genetics. There are several conventional as well as advanced devices and platforms indicated to diagnose, treat, and monitor these urological disorders.

Global Urology Care Devices and Platforms Market (by Region)

The different regions covered under the global urology care devices and platforms market report include North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.

North America dominated the global urology care devices and platforms market in 2019 and is anticipated to uphold its dominance throughout the forecast period.The growth in the market is majorly driven by the increasing research and development activities and large-scale adoption of global urology care devices and platforms.

Also, the ongoing trend for digital transformation through the development of platforms and mobile applications is putting a significant impact on the market growth.

Key Market Players and Competition Synopsis

Avenda Health, B. Braun Melsungen AG, Becton, Dickinson and Company, Boston Scientific Corporation, Cardinal Health, Inc., Cook Group, Fresenius Medical Care AG & Co. KGaA, Intuitive Surgical, Inc., KARL STORZ SE & Co KG, Lucida Medical Ltd, Medtronic plc, Px HealthCare Ltd., Richard Wolf GmbH, Rocamed, and Urologix, LLC.

The global urology care devices and platforms market has witnessed several strategic and technological developments in the past few years, undertaken by the different market players to attain their respective market shares in this emerging domain. Some of the strategies covered in this segment are regulatory and legal activities, partnerships and alliances, new offerings, mergers and acquisitions, expansion activities, and funding activities.

Countries Covered
• North America
• U.S.
• Canada
• Europe
• Germany
• Italy
• France
• Spain
• U.K.
• Rest-of-Europe
• Asia-Pacific
• China
• India
• Japan
• South Korea
• Australia and New Zealand
• Rest-of-Asia-Pacific
• Latin America
• Brazil
• Mexico
• Argentina
• Rest-of-Latin America
• Middle East and Africa
• K.S.A.
• Israel
• South Africa
• Rest-of-Middle East and Africa (Rest-of-MEA)
Read the full report: https://www.reportlinker.com/p06124032/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.

__________________________


GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Artificial Intelligence

Appian Named a Leader in the 2024 Gartner® Magic Quadrant™ for Process Mining Platforms Report

Published

on

appian-named-a-leader-in-the-2024-gartner-magic-quadrant™-for-process-mining-platforms-report

LONDON, May 3, 2024 /PRNewswire/ — Appian (Nasdaq: APPN) today announced it has been named a Leader by Gartner in its 2024 Magic Quadrant for Process Mining Platforms report. The report evaluated 18 vendors and their product offerings. For more information, download a complimentary copy of the Gartner Process Mining 2024 report. 

Gartner defines Process Mining platforms as tools that deliver visibility and insights to technology innovation leaders that enable smart decision making and strong performance on an organisation’s critical priorities. Features that make Appian a leader in Process Mining, include:
Faster data prep that eliminates complex transformation with always-ready data from multiple sources.Automated process analysis and intelligent recommendations for where and how to take action.A low-code experience for measuring, monitoring, and optimising process performance—all within one platform.”We believe that Appian’s recognition in the Gartner Process Mining Platforms Magic Quadrant underscores our dedication to process excellence. Through Process HQ, we integrate data fabric, process mining, machine learning, and generative AI to streamline manual data prep, enabling businesses to gain insights swiftly and implement improvements easily,” said Michael Beckley, CTO and Founder of Appian. “Our unified approach merges Process Mining with AI-driven process automation, setting a new standard for efficiency and intelligence.”
Business users need greater visibility into the full breadth of their enterprise data and processes in order to maximise operational efficiency and strategic decision-making. By combining the latest technologies in data fabric, process mining, machine learning, and generative AI, Process HQ helps monitor and improve every business process built on Appian. Process HQ makes it easy to reduce costs, risks, and delays, improve compliance, and drive better business outcomes, without the need for costly and time-consuming data collection efforts.
Appian is now an industry leader across its value proposition to Design, Automate, and Optimise the most complex business processes. In addition to today’s announcement, Appian was named a Leader in the 2023 Gartner® Magic Quadrant™ for Enterprise Low-Code Application Platforms report, and was ranked #1 for the Business Workflow Automation with Integration Use Case in the 2023 Gartner® Critical Capabilities for Enterprise Low-Code Application Platforms (LCAP) report.
To access the report and to learn more about Appian’s positioning, visit https://ap.pn/3y2ClZy. Register for our upcoming webinar Process Intelligence Made Easy: The Key to Better Business Decisions on June 20, 2024 at 12pm EST to discover how Process HQ can improve business processes.
Gartner disclaimerGartner does not endorse any vendor, product or service depicted in our research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner research organisation and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose. GARTNER is a registered trademark and service mark of Gartner and Magic Quadrant is a registered trademark of Gartner, Inc. and/or its affiliates in the U.S. and internationally and are used herein with permission. All rights reserved.
About Appian
Appian is a software company that automates business processes. The Appian AI Process Platform includes everything you need to design, automate, and optimise even the most complex processes, from start to finish. The world’s most innovative organisations trust Appian to improve their workflows, unify data, and optimise operations—resulting in better growth and superior customer experiences. For more information, visit appian.com. [Nasdaq: APPN]
Follow Appian: LinkedIn, X, and X (UK).
Photo – https://mma.prnewswire.com/media/2403879/Appian_Garter_Gartner_MQ_ProcessMining.jpg
Logo – https://mma.prnewswire.com/media/1948800/Appian_400px_Blank_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/appian-named-a-leader-in-the-2024-gartner-magic-quadrant-for-process-mining-platforms-report-302135161.html

Continue Reading

Artificial Intelligence

Innodisk Introduces iCAP Air: Advancing Air Quality Management through Autonomous Decision-Making

Published

on

innodisk-introduces-icap-air:-advancing-air-quality-management-through-autonomous-decision-making

TAIPEI, May 3, 2024 /PRNewswire/ — Innodisk, a global leader in AI solutions, has taken a pivotal step forward in environmental sustainability with the launch of its latest innovation, the “iCAP Air” air quality management solution. This solution empowers businesses worldwide to enhance air quality, sustainability, and human health. Additionally, business can benefit from monthly AI-generated air quality data report, providing valuable insights for informed decision-making.

Leveraging its expertise in edge computing and software and hardware integration, along with the expertise of its subsidiary Sysinno in air quality detection, Innodisk has achieved the development of the “iCAP Air” air quality management solution. This solution integrates advanced technology, including the innovative “iAeris7” air quality detector from Sysinno, to deliver accuracy in detecting temperature, humidity, fine suspended particles (PM2.5), suspended particles (PM10), carbon dioxide (CO2), formaldehyde and total volatile organic compounds (TVOC). It can also be customized to detect NO2, SO2, CO, NH3, and other air factors. At the same time, the iAeris7 device is known for its reliability, patented technology, and various international certifications, including those from SGS and FCC/CE/RoHS/NCC/BSMI.
The solution also includes the “iCAP Air Server,” designed to manage large-scale deployment and data from up to 100 air quality detectors, ensuring seamless integration and efficient operation, even in complex environments. Additionally, iCAP Air provides a user-friendly air quality management platform, enabling organizations to monitor air quality in real-time via a mobile app or internet browser, receive automatic alerts, and optimize air purification or exhaust ventilation system.
iCAP Air is a comprehensive solution that simplifies air quality management for users. It is tailored for medium to large-sized sites or densely populated, enclosed spaces such as medical institutions, smart manufacturing facilities, public transportation hubs, indoor parking facilities, and department stores. Innodisk’s “iCAP Air” air quality management solution represents a milestone for all businesses committed to leveraging technology for the greater good of air quality and society.
Photo – https://mma.prnewswire.com/media/2404226/Press_Photo_iCAP_Air_Overview.jpgLogo – https://mma.prnewswire.com/media/826938/Innodisk_Corporation_Logo.jpg 

View original content:https://www.prnewswire.co.uk/news-releases/innodisk-introduces-icap-air-advancing-air-quality-management-through-autonomous-decision-making-302135455.html

Continue Reading

Artificial Intelligence

Bitrue expands Bitcoin Runes Offerings with GPTV Listing and Staking Options

Published

on

bitrue-expands-bitcoin-runes-offerings-with-gptv-listing-and-staking-options

VICTORIA, Seychelles, May 3, 2024 /PRNewswire/ — Leading digital asset exchange Bitrue continues its community-driven approach with the listing of a new Bitcoin Runes token, GPTV•AI•PEPE•KING (GPTV). This follows the recent addition of several other Bitcoin Runes tokens to the platform, including SATOSHI•NAKAMOTO (SATOSHI), LOBO•THE•WOLF•PUP (LOBO), RSIC•GENESIS•RUNE (RSIC), and DOG•GO•TO•THE•MOON (DOG). Trading for the GPTV/USDT pair commenced on April 30th, 2024.

What is GPTV?
GPTV is the native token of AI PEPE KING, a project claiming to be the “largest AI Meme Community” with a presence on both the Polygon (AIPEPE) and Bitcoin Runes (GPTV) blockchains. Notably, AI PEPE KING secured a $10 million investment to develop AI-powered customer service tools leveraging the ChatGPT technology. Additionally, they are building a “Dream Lottery” system. Revenue generated from these products is earmarked for buybacks and burns of both AIPEPE and GPTV tokens, potentially influencing their long-term value.
Staking Opportunities with Attractive Yields
Bitrue is also offering users staking opportunities for those holding BTR, AIPEPE, RSIC, or DOG tokens. By staking their holdings, users can earn rewards in GPTV, with estimated annual percentage yield (APY) varying on the staked token, with BTR offering 22.15%, AIPEPE at 23.18%, RSIC boasting a higher 31.37%, and DOG coming in at 23.62%. These yields present a potentially lucrative opportunity for users to grow their cryptocurrency holdings, but also come with financial risk and the potential for investment to return much lower yields.
Bitrue’s Focus on Community Engagement
The listing of these Bitcoin Runes tokens is a testament to Bitrue’s commitment to its user base. The decision to add these tokens stemmed from a community poll conducted through an X poll on Bitrue’s X account. This highlights the exchange’s dedication to incorporating community feedback into its decision-making process, fostering a sense of collaboration and shared interest.
With the addition of GPTV and the introduction of staking opportunities, Bitrue continues to expand its offerings for users interested in the burgeoning world of Bitcoin Runes tokens. The exchange’s focus on community engagement further strengthens its position as a platform that prioritizes user input and satisfaction.
About Bitrue
Launched in July 2018, Bitrue is a diversified digital asset exchange that supports trading, loans and investments. Bitrue aims to utilize blockchain technology to bring financial opportunities to everybody regardless of their location or financial position. With offices in Asia and Europe, the business continues to develop new features at a rapid speed to fully service the new wave of the digital economy. More information is available at Bitrue’s website.
Logo – https://mma.prnewswire.com/media/2385358/Bitrue_BitrueOfficial_Bitrue_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/bitrue-expands-bitcoin-runes-offerings-with-gptv-listing-and-staking-options-302135402.html

Continue Reading

Trending